Westlake stock
WLKNYSEWestlake Corporation, Basic MaterialsISIN US9604131022
39Score 39 out of 100, Weak
Price and trend
35 / 100
Price history
0.0% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 27% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 45).
The price is 49% below its 52-week high. Largest decline in 20 years: 76% (May 2018 to March 2020).
Chart figures for advanced users
- SMA 50$66.20
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$86.07
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)45
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$56.38
- The lowest closing price of the last twelve months.
- Resistance$123.39
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Westlake Corporation belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $8.03B, is number 38 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $11.17B (down 8% year on year) and a loss of $1.51B.
- For fiscal 2026, analysts expect on average revenue of $11.57B (up 3.6%) and adjusted earnings per share of $1.68.
Show more
- MEQIRI Score 39 out of 100 (Weak): rank 407 of 467 in Basic Materials, median 58.
- Our model puts fair value at $39.14, with the price 63% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for 21 years.Capital allocation 50
- Analysts expect strong earnings growthUp 20.1% a year through 2028 (estimates from 9 analysts).
- High dividend yieldDividend yield 3.32%, Chemicals (Specialty) median 1.97%.Capital allocation 50
Weaknesses
- Margin fallingOperating margin −14.1%, average of the prior years 7.2% (to 2024).Profitability 12
- Dividend not coveredPayouts over the last 12 months were 145% of earnings and 2,275% of free cash flow.Capital allocation 50
- Loss-makingLoss of $447M over the last 12 months.Fundamentals 60
The score is held back by growth and profitability.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- price far below its 52-week high
- high price swings
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
Valuation
Valuation signal
Modestly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $27.96 and expensive above $65.23 (uncertainty high, based on the price swings of the past year).
Calculated with a cost of equity of 9.4%. At 10.4% the fair value would be $33.21, at 8.4% it would be $47.65.
Valuation metrics
From the dividend model alone; without earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 0.4% on the twelve months before. Revenue has grown solidly since 2006, at about 8% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 3%, operating −14%, net −14%. Last 12 months: net −4%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 23 Feb 2027in 103 days
- Last reported
- 4 Nov 2026EPS reported $0.45 (expected $0.47)below expectations
Analyst estimates
Analysts have cut their 2026 earnings estimate by 22.7% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $1.68−22.7%
- Revenue
- $11.57B+0.1%
- Earnings per share
- $2.03−20.5%
- Revenue
- $11.89B−0.2%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook lowered
Share price after the results: +12.7%Housing and Infrastructure Products revenue and EBITDA margin are now expected toward the lower end of the previous ranges ($4.4 billion to $4.6 billion, 19% to 21%) on weaker residential construction and higher costs.
“We expect 2026 revenue and EBITDA margin in our Housing and Infrastructure Products segments to be towards the lower end of our previously communicated ranges of $4.4 billion to $4.6 billion of revenue, with EBITDA margin between 19% and 21%, excluding identified items.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 4 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $3.12M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Chao AlbertSale
11 Aug 2026, Executive Chairman
- Shares
- 38,873
- Price
- $80.28
- Value
- $3.12M
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Westlake
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 39
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Sinoma Science & Technology002080.SZ $9.44B42
- Tianqi Lithium002466.SZ $8.78B58
- Guangzhou Tinci Materials Technology002709.SZ $8.51B69
- Element SolutionsESI $8.26B54
- SRFSRF.NS $7.94B59
- Axalta Coating SystemsAXTA $7.93B71
- Eastman ChemicalEMN $7.6B60
- China Rare Earth Resources and Technology000831.SZ $7.57B52
ETFs that hold Westlake
Held by 12 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR S&P U.S. Dividend Aristocrats UCITS ETF (Dist)SPYD | 0.09% | 0.35% | €3.62B |
| State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF (Acc)SPY4 | 0.06% | 0.30% | €5.27B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.06% | 0.35% | €434.1M |
Show 5 more
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.05% | 0.30% | €944.34M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.05% | 0.43% | €2.48B |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.02% | 0.35% | €8.19B |
| Invesco RAFI US Fundamental Value UCITS ETF6PSA | 0.01% | 0.39% | €1.23B |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €175.89M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 17 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.